Paroxetine-CR to Treat Post-Traumatic Stress Disorder (PTSD) Symptomatic After Initial Exposure Therapy

Clinical trial NCT00215163 · COMPLETED

Trial details

NCT number: NCT00215163
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Stress Disorders, Post-Traumatic

Start date: 2002-12-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.